Filana Therapeutics (FLNA) Revenue (2010 - 2026)
Filana Therapeutics (FLNA) posted Revenue of $35.24 million for Q4 2013, compared with $2.47 million a year earlier.
Powered by 
Analysis
Filana Therapeutics (FLNA) Revenue (2010 - 2026) Analysis & Trends
For FY2013, Filana Therapeutics' Revenue came in at $41.12 million, up 277.6% from FY2012.
- Annual Revenue shows a four-year compound annual growth rate of 18.9% (FY2009 to FY2013).
- In prior years, Filana Therapeutics' Revenue was $10.89 million in FY2012 (-5.2%), $11.48 million in FY2011 (-31.7%), $16.81 million in FY2010 (-18.3%) and $20.56 million in FY2009.
- The Q4 2013 figure stands as the highest quarterly Revenue in data going back to Q2 2010.
- The strongest year-over-year quarter for Revenue in the past five years was Q2 2011, with growth of 3.6%; the weakest was Q4 2011, with a decline of 65.7%.
- According to Business Quant data, Revenue for the three prior quarters was $1.96 million (Q3 2013), $1.96 million (Q2 2013) and $1.96 million (Q1 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Filana Therapeutics | 33.61 Mn | -337.23 Mn | - | 747,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 747,000.00 |
| Mar 31, 2026 | 789,000.00 |
| Dec 31, 2025 | 974,000.00 |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.27 Mn |
| Dec 31, 2024 | 1.80 Mn |
| Sep 30, 2024 | 2.62 Mn |
| Jun 30, 2024 | 2.32 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Sep 30, 2023 | 2.01 Mn |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 2.05 Mn |
| Dec 31, 2022 | 1.55 Mn |
| Sep 30, 2022 | 878,000.00 |
| Dec 31, 2013 | 35.24 Mn |
| Sep 30, 2013 | 1.96 Mn |
| Jun 30, 2013 | 1.96 Mn |
| Mar 31, 2013 | 1.96 Mn |
API Access
Filana Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=FLNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "FLNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=FLNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();